Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trial
Ryan Yen, Sarah Grasedieck, Andrew Wu, Hanyang Lin, Jiechuang Su, Katharina Rothe, Helen Nakamoto, Donna L. Forrest, Connie J. Eaves, Xiaoyan Jiang
Topics & Concepts
NilotinibMedicineOncologyMyeloid leukemiaInternal medicineHazard ratiomicroRNAProportional hazards modelLeukemiaMyeloidImmunologyImatinibBiologyConfidence intervalGeneBiochemistryChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and Treatment